Veeral Ajmera
Papers
1
Total Citations
8
H-Index
1
About
Dr. Veeral Ajmera is a clinician-scientist whose research focuses on the genetic and molecular determinants of severe liver diseases, particularly hepatitis B virus (HBV) infection and acute liver failure. His most cited work, "Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus–Related Acute Liver Failure" (2018, 8 citations), represents a significant contribution to understanding why only a small fraction of HBV-exposed individuals develop life-threatening hepatic decompensation. By identifying a specific host genetic polymorphism in the CXCL16 chemokine gene, Dr. Ajmera’s research illuminates how inherited variations in immune signaling pathways can influence susceptibility to HBV-related acute liver failure—a condition with high mortality. This work bridges genomic immunology and hepatology, offering potential biomarkers for risk stratification. Dr. Ajmera’s findings underscore the importance of host genetics in viral hepatitis outcomes, moving beyond traditional virologic factors. His research has implications for personalized monitoring and therapeutic targeting in HBV infection, contributing to the broader effort to reduce the global burden of viral hepatitis. Through this focused genetic investigation, Dr. Ajmera demonstrates how precision medicine approaches can unravel the complex interplay between host and pathogen in severe liver disease.
Research Focus
Key Achievements
Top Papers
- 1